Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma
4 clinical trials · Condition
◉ Watch Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Zanubrutinib in Combination With R-PolaCHP (ZaR-PolaCHP) for Newly Diagnosed Diffuse Large B-Cell Lymphoma (NCT04850495) | Yazeed Sawalha | 2021-11-16 |
| Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma (NCT04799275) | National Cancer Institute (NCI) | 2021-05-20 |
| Pembrolizumab and External Beam Radiation Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NCT03210662) | M.D. Anderson Cancer Center | 2018-02-01 |
Track Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.